The book is currently out of stock
Parameters
More about the book
The KRAS oncogene is believed to be the most common single nucleotide variant oncogene in human cancer. Historically, efforts to target KRAS and the other RAS GTPases have struggled. More recently, efforts have focused on identifying and exploiting features unique to specific oncogenic mutations.
Book purchase
Therapeutic Targeting of RAS Mutant Cancers, Edward C Stites, Kendra Paskvan
- Language
- Released
- 2022
- product-detail.submit-box.info.binding
- (Paperback)
We’ll email you as soon as we track it down.
Payment methods
No one has rated yet.